Skip to content.
|
Skip to navigation
Personal tools
Log in
Français
English
Centre International de
Recherche en Infectiologie
Search Site
only in current section
Advanced Search…
Research and Support Teams
BAIZE S-UBIVE
CHARPENTIER X-Horigene
CIMARELLI A-LP2L
COSSET FL-EVIR
DOUBLET P-JARRAUD S-LegioPath
DREUX M-VIV
DURANTEL D-HepVir
DUTARTRE H/JOURNO C-OR
FAURE M-APY
GENESTIER L/BACHY E - LIB
HENRY T-I2BA
HORVAT B-IbIV
LINA B-CALATRAVA M-VirPath
LOTTEAU V-VIRIMI
MARVEL J-ICL
MATHIEU C-NITROVIRE
OHLMANN T-REVE
PAUL S-GIMAP
PERSONNIC N-PERSIST
PY B-NLRP3
ROUSSET F-GENOMIC
THAUNAT O-NOPAB
VANDENESCH F-Stapath
VANHEMS P-PHE3ID
VOCANSON M-EIA
VOLCHKOV V-MBPV
WALZER T-LYACTS
Sections
Home
The Center
Governance of the CIRI
Comittees and commissions
Support teams
Localisations
Teaching
Clinical research
Research
Bacteriology
Immunolgy
Virology
All teams
Intramural CIRI Projects
Clinical research
Teams
Anciennes équipes
News
Directory
JOIN US
Intranet
You are here:
Home
/
Teams
/
Durantel D - HepVir
/
What's new for us?
/
A novel in vitro system for simultaneous infections with hepatitis B, C, D and E viruses
Info
A novel in vitro system for simultaneous infections with hepatitis B, C, D and E viruses
Fouillé et al., J Hep Reports, 2025 / Team HepVir
Navigation
What do we do?
Who are we?
What did we publish?
Who are our sponsors?
Who are our collaborators?
Social media?
How to contact us?
What's new for us?
Interplay Between CMGC Kinases Targeting SR Proteins and Viral Replication: Splicing and Beyond
PhD defense from Manon Desmares, team HepVir
Evidence for long-term association of virion-delivered Hepatitis B virus Core protein with cccDNA independently of viral protein production
Inducers of the NF-κB pathways impair Hepatitis Delta virus (HDV) replication & strongly decrease progeny infectivity in vitro
Inhibitory Effect of IL-1b on HBV and HDV Replication and HBs Antigen-Dependent Modulation of Its Secretion by Macrophages
PhD defense of Marion Delphin, team HepVir
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method
Congrès International HBV 2022
Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes
A stable hepatitis D virus-producing cell line for host target and drug discovery
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against HBV
Un monde de Virus, Médecine Science
Farnesoid X receptor alpha ligands inhibit hepatitis delta virus in vitro replication and virion infectivity
Interferon-dependent and independent mechanisms drive Hepatitis Delta Virus interference on Hepatitis B Virus RNA production
Deciphering the phospho-signature induced by hepatitis B virus in primary human hepatocytes
The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA
A novel in vitro system for simultaneous infections with hepatitis B, C, D and E viruses
Soutenance de thèse de Cassandre Authier / Equipe HepVir (19/05/2025)
TRIM proteins: A ‘swiss army knife’ of antiviral immunity
LES QUAIS DU POLAR 2026 FONT LEUR RECHERCHE
To which events are we part of?
Would you like to join us?
